| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |